Latest Biotech News

Researchers at Sichuan University have engineered edible microbeads inspired by boba pearls that absorb dietary fats locally within the gut, offering a potential alternative to systemic weight...

Cascala Health, a Boston-based startup, secured $8.6 million in seed funding to expand its artificial intelligence platform designed for risk-bearing healthcare providers. The platform aims to...

A genome-wide CRISPR/Cas9 screen revealed SUV39H2, a histone methyltransferase, as a key mediator of resistance to oncolytic herpes simplex virus 1 (oHSV-1) in oral squamous cell carcinoma (OSCC)....

Researchers have developed a pioneering antibody capable of crossing the blood-brain barrier to target alpha-synuclein aggregates, the pathological hallmark of synucleinopathies such as...

A new personalized liquid biopsy assay named MRD4U offers unprecedented sensitivity for monitoring central nervous system tumors in children. Detailed in BMC Cancer, this genomic tool allows...

A novel approach integrating deep learning and multiparametric MRI-based habitat analysis accurately predicts perineural invasion in prostate cancer patients. This two-center study demonstrates...

A recent study using data from the National Health and Nutrition Examination Survey (NHANES) identified the Unrecognized Hyperglycemia Risk (UHR) threshold as a promising new biomarker for early...

Precigen’s Papzimeos, the first FDA-approved immunotherapy for recurrent respiratory papillomatosis, has blockbuster potential in the rare tumor market. However, recent financial disclosures...

New research highlights that neural stem cell-derived exosomes can alleviate neurodegeneration in Parkinson’s disease models induced by MPTP neurotoxins. These extracellular vesicles mediate...

Sichuan University scientists developed edible microbeads that selectively trap dietary fats in the gastrointestinal tract, showing promise in weight management without systemic drug exposure....

Boston-based startup Cascala Health secured $8.6 million in seed funding to expand its artificial intelligence platform aimed at improving patient care transitions. The platform targets...

LB Pharma is preparing to test the IPO market as its antipsychotic drug nears Phase III clinical trials. This development comes amid growing interest in neuropsychiatric therapeutics, with LB...

Researchers used a CRISPR/Cas9 genome-wide screen to identify SUV39H2, a histone methyltransferase, as a key driver of resistance to oncolytic herpes simplex virus 1 (oHSV-1) therapy in oral...

A newly engineered brain-delivered antibody targeting alpha-synuclein aggregates, implicated in synucleinopathies like Parkinson’s disease, demonstrates potential for mitigating neurodegeneration....

Researchers led by Wu, Zhang, and Zhang have developed a generalist foundational AI model that integrates both two-dimensional and three-dimensional medical imaging data at scale. This novel model...

The MRD4U assay represents a new personalized liquid biopsy technique designed to monitor central nervous system tumors in children with high sensitivity. This development may enable earlier...

Yu and colleagues identified a novel biomarker termed Unrecognized Hyperglycemia Risk (UHR) that improves early diabetes detection. This biomarker, emerging from National Health and Nutrition...

In a cutting-edge educational initiative, Li, Wu, and Zhang introduced virtual reality (VR) with a flipped classroom and collaborative role-playing to nursing training. This innovative approach...

Develop Health secured $14.3 million in Series A funding led by Wing Venture Capital to enhance its platform streamlining prior authorization processes. This investment supports the company's...

A two-center study employing deep learning and multiparametric MRI habitat analysis has developed a method to predict perineural invasion in prostate cancer. This approach promises to refine...